JPMorgan Chase & Co. lowered shares of Cabot (NYSE:CBT – Get Rating) from an overweight rating to a neutral rating in a research note released on Tuesday, The Fly reports. JPMorgan Chase & Co. currently has $80.00 price objective on the specialty chemicals company’s stock, down from their previous price objective of $87.00. Several other […]
Dorsey Wright & Associates purchased a new position in shares of Cabot Co. (NYSE:CBT – Get Rating) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 3,771 shares of the specialty chemicals company’s stock, valued at approximately $252,000. Several […]
Mitsubishi UFJ Trust & Banking Corp lifted its stake in shares of Cabot Co. (NYSE:CBT – Get Rating) by 25.3% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 976 shares of the specialty chemicals company’s stock after buying an additional 197 shares during […]
PAX Financial Group LLC bought a new stake in Cabot Co. (NYSE:CBT – Get Rating) during the fourth quarter, Holdings Channel reports. The institutional investor bought 4,747 shares of the specialty chemicals company’s stock, valued at approximately $317,000. Several other hedge funds and other institutional investors have also added to or reduced their stakes in […]
StockNews.com began coverage on shares of Cabot (NYSE:CBT – Get Rating) in a research report sent to investors on Thursday morning. The firm issued a buy rating on the specialty chemicals company’s stock. A number of other brokerages have also weighed in on CBT. JPMorgan Chase & Co. raised their price objective on Cabot from […]